<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0011380"><a href="http://purl.obolibrary.org/obo/MONDO_0011380">MONDO:0011380</a></h3>
<p><strong>Label:</strong> leukoencephalopathy with vanishing white matter</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0020506">MONDO:0020506</a> (Ovarioleukodystrophy),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_615889">OMIM:615889</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603896">OMIM:603896</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99853">Orphanet:99853</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0031212">HP:0031212</a> (Abnormal circulating progesterone level) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008233">HP:0008233</a> (Decreased circulating progesterone) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006980">HP:0006980</a> (Progressive leukoencephalopathy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004485">HP:0004485</a> (Cessation of head growth) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0100543">HP:0100543</a> (Cognitive impairment) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0031066">HP:0031066</a> (Abnormal ovarian physiology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0012547">HP:0012547</a> (Abnormal involuntary eye movements) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0011446">HP:0011446</a> (Abnormality of higher mental function) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0011443">HP:0011443</a> (Abnormality of coordination) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0011283">HP:0011283</a> (Abnormality of the metencephalon) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0011282">HP:0011282</a> (Abnormality of hindbrain morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0008209">HP:0008209</a> (Premature ovarian insufficiency) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0007367">HP:0007367</a> (Atrophy/Degeneration affecting the central nervous system) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006970">HP:0006970</a> (Periventricular leukomalacia) and <a href="http://purl.obolibrary.org/obo/HP_0006980">HP:0006980</a> (Progressive leukoencephalopathy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006808">HP:0006808</a> (Cerebral hypomyelination) and <a href="http://purl.obolibrary.org/obo/HP_0040194">HP:0040194</a> (Increased head circumference) 66.67%</li>
</ul>
</body>
</html>
